Skip to main content

Table 3 Change in each IBSSI-J component score from baseline at each evaluation point

From: Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

 

Week 4

Week 8

Week 12

Last point

Placebo

Ramosetron

Placebo

Ramosetron

Placebo

Ramosetron

Placebo

Ramosetron

5 μg

 

5 μg

 

5 μg

 

5 μg

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

P value

P value

P value

P value

P value

P value

P value

P value

N

48

46

49

44

47

44

50

47

Overall scores

−75.0 ± 81.52

−95.9 ± 105.12

−103.0 ± 81.81

−130.6 ± 114.27

−110.3 ± 97.04

−137.0 ± 113.18

−108.2 ± 94.44

−133.5 ± 110.72

P = 0.283

P = 0.181

P = 0.231

P = 0.228

Severity of abdominal pain

−15.3 ± 25.18

−17.0 ± 25.15

−21.4 ± 28.46

−24.3 ± 27.41

−21.9 ± 30.42

−26.6 ± 27.01

−21.9 ± 29.76

−26.1 ± 26.41

P = 0.743

P = 0.625

P = 0.439

P = 0.467

Frequency of abdominal pain

−16.5 ± 25.89

−20.0 ± 32.52

−24.7 ± 29.38

−26.6 ± 35.04

−25.1 ± 32.56

−28.2 ± 35.13

−24.6 ± 31.77

−28.1 ± 33.98

P = 0.560

P = 0.777

P = 0.666

P = 0.603

Intensity of abdominal distension

−9.7 ± 23.13

−16.3 ± 27.68

−12.2 ± 24.54

−17.8 ± 26.66

−11.5 ± 25.83

−16.6 ± 29.88

−10.8 ± 25.26

−16.3 ± 29.22

P = 0.214

P = 0.295

P = 0.385

P = 0.325

Dissatisfaction with bowel habits

−16.2 ± 31.23

−20.8 ± 28.18

−19.2 ± 33.55

−31.4 ± 29.88

−25.1 ± 33.57

−33.4 ± 31.50

−24.8 ± 33.84

−32.5 ± 30.63

P = 0.454

P = 0.067

P = 0.230

P = 0.243

Interference with QOL

−17.3 ± 27.76

−21.8 ± 29.94

−25.5 ± 27.75

−30.5 ± 34.84

−26.7 ± 28.67

−32.2 ± 32.53

−26.1 ± 28.04

−30.6 ± 32.44

P = 0.454

P = 0.445

P = 0.396

P = 0.470

  1. Data are expressed as mean ± standard deviation. P values were calculated using analysis of variance